NBCAPITAL.NET
NB CapitalRepresentative Investments by Florian Schönharting Role: Co-Founder Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and autoimmune diseases, based on proprietary next generation antibody technologies. Ticker: GEN.CO - Market cap:
http://www.nbcapital.net/


